Zynex, Inc. logo

Zynex, Inc. (ZYXI)

Delisted
2 Apr 2026
NASDAQ (NGS) NASDAQ (NGS)
$
0. 12
+0.07
+140.3846%
$
1.67M Market Cap
47.57 P/E Ratio
- Div Yield
274,571 Volume
0.51 Eps
$ 0.05
Previous Close
Day Range
0.12 0.12
Year Range
0.03 8.45
Want to track ZYXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

ZYXI Chart

Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript

Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript

Zynex, Inc. ( ZYXI ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call.

Seekingalpha | 9 months ago
Zynex taps adviser Province, forms special board committee to review strategic options

Zynex taps adviser Province, forms special board committee to review strategic options

Zynex Inc (NASDAQ:ZYXI) said on Friday it has hired financial advisory firm Province LLC and formed a special board committee to evaluate a range of strategic alternatives. The company said Province will assist in reviewing options that include potential capital-raising, recapitalization and restructuring strategies.

Proactiveinvestors | 9 months ago
Zynex welcomes Steve Dyson as CEO, adds to leadership team

Zynex welcomes Steve Dyson as CEO, adds to leadership team

Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.

Proactiveinvestors | 1 year ago

Zynex, Inc. (ZYXI) FAQ

What does "Delisted" mean?

Zynex, Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

The last recorded dividend was paid on Jan 05, 2022 in the amount of $0.09 per share.

How long did the company pay dividends?

The company paid dividends for 3 years prior to delisting.

Were there any stock splits?

The last recorded stock split occurred on Jan 05, 2022 with a ratio of 110:100.

What was the last known trading price?

The stock last traded at $0.12 on Apr 02, 2026 before being delisted.

Zynex, Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Steven Lewis Dyson CEO
NASDAQ (NGS) Exchange
98986M103 CUSIP
US Country
1,000 Employees
21 Jan 2022 Last Dividend
16 Dec 2003 Last Split
31 Dec 2002 IPO Date

Overview

Zynex, Inc., established in 1996 and headquartered in Englewood, Colorado, is a prominent company that specializes in designing, manufacturing, and marketing innovative medical devices aimed at treating chronic and acute pain, as well as facilitating muscle rehabilitation. Through its subsidiaries, Zynex has developed a reputation for creating devices that use electrical stimulation to aid in pain management and muscle activation. The company’s commitment to improving patient outcomes is evident through its diverse product portfolio, which caters to a wide range of medical needs, including pain management, stroke and spinal cord injury rehabilitation, and hemodynamic monitoring. Zynex's approach to the market involves direct sales primarily in the United States, utilizing a team of dedicated field sales representatives to engage with physicians and therapists.

Products and Services

  • NexWave: This dual channel, multi-modality device provides interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES), marketed primarily to physicians and therapists. NexWave is aimed at the treatment of various pain conditions and muscle rehabilitation.
  • NeuroMove: Focused on aiding stroke and spinal cord injury recovery, the NeuroMove is an electromyography triggered electrical stimulation device designed to encourage neuromuscular reeducation and function restoration.
  • InWave: Developed for the treatment of female urinary incontinence, the InWave product utilizes electrical stimulation to strengthen pelvic floor muscles, thereby addressing this widespread condition.
  • E-Wave: This NMES device targets muscle activation and exercise, promoting the rehabilitation and strengthening of muscles through controlled electrical stimulation.
  • Private Labeled Products: Zynex also offers a range of private labeled products, including electrodes for electrical current delivery to the body and batteries for electrotherapy devices, enhancing the effectiveness and usability of its solutions.
  • Comfortrac/Saunders: Distributed by Zynex, these products offer cervical traction solutions designed to alleviate neck pain and improve spinal health.
  • JetStream: This product provides hot/cold therapy for pain relief and muscle recovery, catering to a variety of therapeutic needs.
  • LSO Back Braces: For lumbar support, the LSO Back Braces are designed to assist with lower back pain management and posture improvement.
  • Knee Braces: Aimed at knee support, these braces offer stability and relief for individuals with knee-related conditions or injuries.
  • Zynex Fluid Monitoring System (CM-1500): A non-invasive medical device for monitoring relative fluid volume changes in operating and recovery rooms, crucial for detecting fluid loss during surgery and internal bleeding during recovery.
  • Zynex Wireless Fluid Monitoring System (CM-1600): This advanced, noninvasive monitoring device measures relative changes in fluid volume in adult patients, enhancing patient care and monitoring capabilities.
  • NiCO CO-Oximeter and HemeOx tHb Oximeter: These laser-based, noninvasive devices provide critical measurement of blood oxygenation and total hemoglobin levels, supporting comprehensive hemodynamic monitoring during medical care.

Contact Information

Address: 9655 Maroon Circle
Phone: 303 703 4906